ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $7,000 | -22.2% | 42 | -42.5% | 0.00% | – |
Q2 2021 | $9,000 | -18.2% | 73 | -7.6% | 0.00% | – |
Q1 2021 | $11,000 | +83.3% | 79 | +68.1% | 0.00% | – |
Q4 2020 | $6,000 | 0.0% | 47 | -19.0% | 0.00% | – |
Q2 2020 | $6,000 | +50.0% | 58 | +45.0% | 0.00% | – |
Q1 2020 | $4,000 | +300.0% | 40 | +110.5% | 0.00% | – |
Q4 2019 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | – | 19 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
RA Capital Management | 318,565 | $11,529,000 | 1.19% |
OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
QVT Financial LP | 636,764 | $23,044,000 | 0.87% |